Navigation Links
Cadence Pharmaceuticals Reports Third Quarter 2013 Financial Results
Date:11/5/2013

012. For the nine months ended September 30, 2013, Cadence's net product revenue was $77.2 million, an increase of 134% from the $33.0 million reported for the same period in 2012.

For the three months ended September 30, 2013, Cadence reported a net loss of $6.9 million, or $0.08 per share, compared to a net loss of $15.9 million, or $0.19 per share, for the comparable period in 2012. For the nine months ended September 30, 2013, Cadence reported a net loss of $20.2 million, or $0.24 per share, compared to $59.6 million, or $0.70 per share, for the nine months ended September 30, 2012.  Included in the company's net loss for the nine months ended September 30, 2013, was a gain of $7.7 million recorded with respect to the waiver, termination and sale of Cadence's Incline assets in January 2013, for which the company received cash payments totaling $14.7 million.

The Company's gross margin on sales of OFIRMEV for the three months ended September 30, 2013, was 66%, compared to 56% for the same period in 2012. For the nine months ended September 30, 2013, Cadence reported a gross margin of 66%, compared to 51% for the same period in 2012. These year-over-year increases were primarily the result of lower freight costs in 2013 and the impact of price increases implemented in 2012 and 2013. Operating expenses, including patent amortization, increased $2.2 million, or 10%, for the three months ended September 30, 2013, to $24.8 million, from $22.6 million for the same period in 2012. This increase was primarily attributable to higher legal expenses related to the company's intellectual property litigation and the timing of marketing programs, partially offset by lower research and development expenses. For the nine months ended September 30, 2013, Cadence reported operating expenses of $75.4 million, an increase of $2.1 million, or 3%, as compared to $73.3 million for the same period in 2012. This increase was primarily attributable to higher lega
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2013 Financial Results On November 5, 2013
2. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2013 On September 11, 2013
3. Cadence Pharmaceuticals Comments on USPTOs Non-Final, Initial Office Action on Reexamination of Patent
4. Cadence Pharmaceuticals Appoints Laureen DeBuono to its Board of Directors
5. Cadence Pharmaceuticals To Present At The 2013 Wedbush PacGrow Life Sciences Management Access Conference On August 13, 2013
6. Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results
7. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2013 Financial Results On July 31, 2013
8. Cadence Pharmaceuticals To Present At Three Investment Conferences During The Month Of May 2013
9. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013
10. Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
11. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Sept. 15, 2014 Research and Markets ... (CAS 103-90-2) Market Research Report 2014" report to ... Market Research Report 2014 presents comprehensive data on paracetamol ... , Asia , North ... includes paracetamol (acetaminophen) description, covers its application areas and ...
(Date:9/15/2014)... 15, 2014  MedExpress Urgent Care, a national leader in ... flu shots for ages four and up at each of ... get their flu shot early. According to ... of June, making late summer and early fall an ideal ... Vice President of Provider and Clinical Quality, Thomas Pangburn ...
(Date:9/15/2014)... PLYMOUTH MEETING, Pa. , Sept. 15, 2014 /PRNewswire/ ... today that it has met the stringent listing criteria ... has transferred to this U.S. stock exchange from the ... its current ticker symbol, "INO." NASDAQ ... Market, maintains the highest initial listing standards of any ...
Breaking Medicine Technology:Paracetamol (Acetaminophen) (CAS 103-90-2) Market Research Report 2014 2Paracetamol (Acetaminophen) (CAS 103-90-2) Market Research Report 2014 3MedExpress Quotes Late Summer, Early Fall As Best Time to Receive Flu Shot 2Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange 2Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange 3
... TOPAZ Technologies, a leading provider of biomedical research ... ML Weekes & Company, a professional services firm ... strategic partnership.  As a result of this partnership, ... solution through ML Weekes & Company,s RAMS grantsERA ...
... Texas, Nov. 16, 2010 Argon Medical Devices, Inc. ... licensing agreement with Rex Medical, LP ("Rex Medical") for ... dialysis catheter ™ on a global basis. UltraStream ™ ... patients receiving dialysis treatments. Argon will be ...
Cached Medicine Technology:TOPAZ Technologies and ML Weekes & Company Announce Partnership 2TOPAZ Technologies and ML Weekes & Company Announce Partnership 3Argon Medical Devices Announces Exclusive License and Distribution Agreement for 'UltraStream™' Chronic Hemodialysis Catheter 2
(Date:9/16/2014)... Spings, OH (PRWEB) September 16, 2014 ... Master of Arts in Clinical Mental Health Counseling ... joins a growing list of programs offered through Antioch’s ... spring semester starting January 2015. , "Antioch University New ... strong reputation in the field and a track record ...
(Date:9/16/2014)... QuickMedical, a national leader in the ... veteran-owned small business has officially launched three new ... Nipro Medical, and CP Medical Sutures. , ... best, most affordable medical equipment and supplies. To ... effort to reach new medical facilities, QuickMedical has ...
(Date:9/16/2014)... VA (PRWEB) September 16, 2014 The ... of Virginia this fall. Reflecting on what it means ... Expanding Community Vision investigates unique and thought-provoking topics. , ... to be inspired to look at their world differently. ... and set the stage for truly enlightening dialogue,” says ...
(Date:9/16/2014)... CA (PRWEB) September 16, 2014 Today, ... Annual Action Icon Awards to be held, Sunday, October ... Los Angeles. The annual awards show honors the ... actresses and extreme sports stars. Over 12 categories ... hosted by ESPN’s Kenny Mayne. , Special honors ...
(Date:9/16/2014)... September 16, 2014 Triad Semiconductor, Inc. ... CEO of Intersil and former President of Linear Technology ... , “David has extraordinary technology and business expertise, and ... of directors,” said Lynn Hayden, Triad CEO and chairman. ... analog and mixed signal semiconductor experience to Triad's board. ...
Breaking Medicine News(10 mins):Health News:Antioch University Launches Online Master’s Degree Program in Clinical Mental Health Counseling 2Health News:Expanding Community Vision at the Science Museum of Virginia 2Health News:Hollywood's Action Icon Awards to Honor Legendary Stuntwomen In A Star-Studded Gala and Awards Ceremony 2Health News:David Bell Joins Triad Semiconductor's Board of Directors 2
... use vitamin supplements for good health despite the fact that ... argues that the best way to stay healthy is a ... because they're worried that food has fewer nutrients than it ... and minerals is freshly picked produce, reported the online edition ...
... will be served at the domestic theme parks of the ... sign movie// and other endorsement deals only with restaurants that ... ,Disney will put the new guidelines into practice ... of 2007, the trans-fats will be completely removed from the ...
... lung disease; Chronic Obstructive Pulmonary Disease (COPD) will affect ... ,Chronic bronchitis and emphysema constitute COPD, which is ... fatigue, shortness of breath and subsequent difficulty in breathing ... at the Hvidovre Hospital in Denmark conducted a 25-year ...
... new study by researchers at Northwestern University has revealed a ... a U.S. regional poison control// center from 2001 through 2004, ... years. , ,Lead researcher Danielle McCarthy said “This study ... abuse. Part of the problem is that people do not ...
... child’s susceptibility to autism is increased with a single gene ... ,This discovery has far-reaching implications because this gene, a ... specifically a brain gene but rather a gene which has ... immune function and gut repair. ,Therefore researchers have ...
... Palmieri, of Imperial College London, on a small group of ... of Vitamin D with the progression of breast cancer to ... of circulating Vitamin D could play a significant role in ... tests of the women who underwent the study have shown ...
Cached Medicine News:Health News:Madhya Pradesh Tops in Implementing Child Health Scheme 2Health News:Risk of Autism doubled with Single Gene Mutation 2
Optipress II Automated Blood Component Extractor for the standardized separation of whole blood into high purity individual components...
The Eppendorf Maxipettor is a continuously adjustable pipette for precise pipetting of volumes up to 10 ml (in 10 l increments). Even liquids with a high vapor pressure or viscosity can be pipetted w...
eValuator fixed-curve diagnostic electrophysiology catheters offer an effective balance between clinical performance and cost....
... Two high performance technologies - Quantum™ ... shaft platform - unite in the ... a high dilatation force balloon with ... Laser bonded Maverick® shaft technology improves ...
Medicine Products: